Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Rheumatoid Arthritis Market: Global Industry Analysis and Forecast 2015 - 2022".

New York, NY -- (SBWire) -- 06/17/2015 --Rheumatoid Arthritis is an autoimmune disease that causes chronic inflammation and pain in the joint parts of the body. Rheumatoid Arthritis commonly affects the joints in the feet, hips, knees, and hands. Rheumatoid Arthritis is an autoimmune disease where the body's immune system mistakenly attacks healthy tissue instead. Increasing number of patients with rheumatoid arthritis, and rise in R&D activities for drug discovery and development are some of the major factors driving the growth of rheumatoid arthritis therapeutics market. Some symptoms of rheumatoid arthritis include pain, swelling, stiffness, and loss of function. The types of diagnosis technique for rheumatoid arthritis are radiographic features of rheumatoid arthritis and blood tests. Some treatment options for rheumatoid arthritis include drugs, surgery, and physical therapy. Drugs for the treatment of rheumatoid arthritis include pain relieving drugs, corticosteroids, disease modifying anti-rheumatic drugs (DMARDs), biologics, and non-biologic drugs. Pain relieving drugs include non-steroidal anti-inflammatory drugs (NSAIDs) such as Celebrex, and Arcoxia. Biologics include Humira, Remicade, Enbrel, MabThera, Orencia, Actemra, Cimzia, Kineret, and Simponi. The type of treatment depends on the person's age, overall health, medical history, and severity of arthritis. Surgeries for the treatment of rheumatoid arthritis include joint replacement, arthrodesis, tendon reconstruction, and synovectomy. Physical therapy includes exercise, orthotic devices to support and align joints, and frequent rest periods between activities.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/rheumatoid-arthritis-market.asp

The global rheumatoid arthritis therapeutics market is categorized based on drugs. Based on drugs, the report covers first line agents and second line agents. The first line agents include NSAIDs, and steroids. The second line agents include DMARDs and biological agents. The DMARDs includes chloroquine, gold salts, penicillamine, and cyclosporine. The biological agents include TNF-? and interleukin-1 inhibitors.

North America has the largest market for rheumatoid arthritis therapeutics followed by Europe. This is due to the increasing number of patients with rheumatoid arthritis, rise in research and development activities, increasing awareness among people about rheumatoid arthritis, and improved healthcare infrastructure in the region. The rheumatoid arthritis therapeutics market in Asia is expected to experience high growth rate in the next few years. This is due to evolving R&D activities for drug discovery and development, increasing government support in the form of funding, growing awareness about the rheumatoid arthritis and its timely diagnosis, and developing healthcare infrastructure in the region. In addition, growing demographics and economies in the developing countries such as India, China, and Japan are expected to lead growth in the rheumatoid arthritis therapeutics market in Asia.

Increasing number of patients with rheumatoid arthritis, rise in healthcare expenditure, and rise in R&D activities in drug discovery and development are the key drivers for the global rheumatoid arthritis therapeutics market. However, high cost of treatment and patent expiries of the rheumatoid arthritis drugs are some of the factors restraining the growth for global rheumatoid arthritis therapeutics market.

Auto-injectors for rheumatoid arthritis treatment, increasing number of mergers and acquisitions, rapid product launches, and rise in number of collaborations and partnerships are some of the latest trends that have been observed in the global rheumatoid arthritis therapeutics market.

Request Full TOC: http://www.persistencemarketresearch.com/toc/4788

Key points covered in the report

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
North America
Europe
Asia
RoW
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
5) The report also provides porters five forces analysis of the market.-

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.